Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intracellular Signaling Pathways Involved in (S)- and (R)-Ketamine Antidepressant Actions.

Literature DB >> 29173705

Intracellular Signaling Pathways Involved in (S)- and (R)-Ketamine Antidepressant Actions.

Panos Zanos¹, Todd D Gould².

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2018 PMID： 29173705 PMCID： PMC5735822 DOI： 10.1016/j.biopsych.2017.10.026

Source DB: PubMed Journal: Biol Psychiatry ISSN： 0006-3223 Impact factor: 13.382

× No keyword cloud information.

10 in total

1. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.

Authors: Nanxin Li; Boyoung Lee; Rong-Jian Liu; Mounira Banasr; Jason M Dwyer; Masaaki Iwata; Xiao-Yuan Li; George Aghajanian; Ronald S Duman
Journal: Science Date: 2010-08-20 Impact factor: 47.728

2. R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine.

Authors: Ji-Chun Zhang; Su-Xia Li; Kenji Hashimoto
Journal: Pharmacol Biochem Behav Date: 2013-12-03 Impact factor: 3.533

3. Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model.

Authors: Chun Yang; Qian Ren; Youge Qu; Ji-Chun Zhang; Min Ma; Chao Dong; Kenji Hashimoto
Journal: Biol Psychiatry Date: 2017-05-31 Impact factor: 13.382

4. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.

Authors: Nanxin Li; Rong-Jian Liu; Jason M Dwyer; Mounira Banasr; Boyoung Lee; Hyeon Son; Xiao-Yuan Li; George Aghajanian; Ronald S Duman
Journal: Biol Psychiatry Date: 2011-02-03 Impact factor: 13.382

Review 5. Signaling pathways underlying the rapid antidepressant actions of ketamine.

Authors: Ronald S Duman; Nanxin Li; Rong-Jian Liu; Vanja Duric; George Aghajanian
Journal: Neuropharmacology Date: 2011-09-02 Impact factor: 5.250

6. Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine.

Authors: Kenichi Fukumoto; Hidetoh Toki; Michihiko Iijima; Takashi Hashihayata; Jun-Ichi Yamaguchi; Kenji Hashimoto; Shigeyuki Chaki
Journal: J Pharmacol Exp Ther Date: 2017-01-23 Impact factor: 4.030

7. Acute suppression of spontaneous neurotransmission drives synaptic potentiation.

Authors: Elena Nosyreva; Kristen Szabla; Anita E Autry; Alexey G Ryazanov; Lisa M Monteggia; Ege T Kavalali
Journal: J Neurosci Date: 2013-04-17 Impact factor: 6.167

8. Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study.

Authors: Jaskaran B Singh; Maggie Fedgchin; Ella Daly; Liwen Xi; Caroline Melman; Geert De Bruecker; Andre Tadic; Pascal Sienaert; Frank Wiegand; Husseini Manji; Wayne C Drevets; Luc Van Nueten
Journal: Biol Psychiatry Date: 2015-11-03 Impact factor: 13.382

9. NMDAR inhibition-independent antidepressant actions of ketamine metabolites.

Authors: Panos Zanos; Ruin Moaddel; Patrick J Morris; Polymnia Georgiou; Jonathan Fischell; Greg I Elmer; Manickavasagom Alkondon; Peixiong Yuan; Heather J Pribut; Nagendra S Singh; Katina S S Dossou; Yuhong Fang; Xi-Ping Huang; Cheryl L Mayo; Irving W Wainer; Edson X Albuquerque; Scott M Thompson; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal: Nature Date: 2016-05-04 Impact factor: 49.962

10. R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.

Authors: C Yang; Y Shirayama; J-c Zhang; Q Ren; W Yao; M Ma; C Dong; K Hashimoto
Journal: Transl Psychiatry Date: 2015-09-01 Impact factor: 6.222

10 in total

11 in total

Review 1. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors: Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal: Pharmacol Rev Date: 2018-07 Impact factor: 25.468

Review 2. Ketamine: Leading us into the future for development of antidepressants.

Authors: Flavia R Carreno; Daniel J Lodge; Alan Frazer
Journal: Behav Brain Res Date: 2020-02-02 Impact factor: 3.332

Review 3. Convergent Mechanisms Underlying Rapid Antidepressant Action.

Authors: Panos Zanos; Scott M Thompson; Ronald S Duman; Carlos A Zarate; Todd D Gould
Journal: CNS Drugs Date: 2018-03 Impact factor: 5.749

Review 4. Mechanisms of ketamine action as an antidepressant.

Authors: P Zanos; T D Gould
Journal: Mol Psychiatry Date: 2018-03-13 Impact factor: 15.992

5. Prophylactic efficacy of 5-HT₄R agonists against stress.

Authors: Briana K Chen; Indira Mendez-David; Victor M Luna; Charlène Faye; Alain M Gardier; Denis J David; Christine A Denny
Journal: Neuropsychopharmacology Date: 2019-10-10 Impact factor: 7.853

6. The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects.

Authors: Chadi G Abdallah; Henk M De Feyter; Lynnette A Averill; Lihong Jiang; Christopher L Averill; Golam M I Chowdhury; Prerana Purohit; Robin A de Graaf; Irina Esterlis; Christoph Juchem; Brian P Pittman; John H Krystal; Douglas L Rothman; Gerard Sanacora; Graeme F Mason
Journal: Neuropsychopharmacology Date: 2018-06-28 Impact factor: 7.853